-
Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids
20 Nov 2025 23:32 GMT
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that given the high rate of non-responsiveness to therapies in adults with …
-
GLX351322-Loaded Nanoparticles Alleviate Chronic Stress-Induced Depressive Behaviors Through Inhibition of Ferroptosis and Oxidative Stress
24 Nov 2025 15:46 GMT
… TRIzol reagent (ET101-01, TransGen Biotech Co., Ltd, China) and … Green Master Mix (AQ601, TransGen Biotech Co., Ltd, China). The … levels of CORT, a steroid hormone that provides the necessary … barriers to drug delivery. Nat Biotechnol. 2015;33:941–951. …
-
Generic Musculoskeletal Disorders Drugs Market to Reach USD $0.08 Billion by 2029 at 6.9% CAGR
24 Nov 2025 10:45 GMT
… Inc., an American pharmaceutical and biotech company, joined forces with Alex …
Subsegments:
1) By Medication: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics …
-
Pain Management Drugs Market is Projected to Increase at a CAGR of 5.6% Through 2025-2029
24 Nov 2025 00:45 GMT
… October 2024, Vertex Pharmaceuticals, a biotech firm based in the US … –
1) By Drug Class: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Anesthetics … Pharmacies
Subsegments:
1) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen …
-
Systemic Lupus Erythematosus Treatment Market to Reach $5.07 Billion by 2029 — Report by The Business Research Company
24 Nov 2025 00:15 GMT
… example, Noxopharm Limited, a biotech firm based in Australia, disclosed … Drug: Antimalarial Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Corticosteroids … , Chloroquine
2) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen …
-
Nanomedicine for Acute Kidney Injury: Precision Delivery Strategies, Therapeutic Breakthroughs, Challenges, and Future Perspectives
22 Nov 2025 00:58 GMT
… causing off-target effects (eg, steroid-induced immunosuppression), low bioavailability due … as immunomodulatory biomaterials. Front Bioeng Biotechnol. 2023;11:1139782. doi:10 … isolation and purification. Front Bioeng Biotechnol. 2021;9:811971. doi:10 …
-
Momordicae Semen: A Review of Phytochemistry, Pharmacology, Toxicology, Herbal Processing, Clinical Applications, and Q-Markers Prediction
22 Nov 2025 00:59 GMT
… lignans, phenolic acids, flavonoids, steroids, proteins, peptides, nitrogenous … MS (271–280).
Steroids
Steroids are also important … -hydroxyl steroids, and 3-glycosides steroids. The steroid compounds found … Univ BAn Int Biomed Biotechnol J. 2007;2007 …
-
Graft Versus Host Disease (GvHD) Treatment Market Trends, Strategies and Investment Opportunities 2025-2030 - CAR-T and Cell Therapy Advancements Generate New Demand for GvHD Management Solutions - ResearchAndMarkets.com
21 Nov 2025 18:45 GMT
… , Antiproliferative Agents, mTOR Inhibitor, Steroids, Other Drug Classes); Organ Transplant … Regions Simplifies Global Product Launches
Biotech M&A Activity … -8900
KEYWORD:
INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH GENETICS STEM CELLS PHARMACEUTICAL …
-
aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as Investor Litigation Over Key Drug’s Efficacy Moves Forward -- Hagens Berman
21 Nov 2025 17:46 GMT
… month as the clinical-stage biotech company reported third-quarter results … to help patients taper off steroids masked underlying deficiencies in the … patient to completely taper their steroid usage, a key measure of …
-
Allergy Conjunctivitis Market Drivers 2025-2029: Regional Outlook and Sizing Analysis
21 Nov 2025 10:00 GMT
… the aging population, breakthroughs in biotechnology, expanding medical services in emerging … ) By Other Drug Classes: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Combination …
About
© 1995-2025